Details for New Drug Application (NDA): 065129
✉ Email this page to a colleague
The generic ingredient in SUPRAX is cefixime. There are fourteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cefixime profile page.
Summary for 065129
Tradename: | SUPRAX |
Applicant: | Lupin Pharms |
Ingredient: | cefixime |
Patents: | 0 |
Suppliers and Packaging for NDA: 065129
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUPRAX | cefixime | FOR SUSPENSION;ORAL | 065129 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-405 | 68180-405-01 | 50 mL in 1 BOTTLE (68180-405-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | 100MG/5ML | ||||
Approval Date: | Feb 23, 2004 | TE: | RLD: | No |
Complete Access Available with Subscription